Theophylline elimination in congestive heart failure

Area of Science:

• Pharmacokinetics
• Cardiology
• Hepatology

Background:

• Theophylline is a medication commonly used for respiratory conditions.
• Chronic congestive heart failure can affect drug metabolism.
• Liver function is crucial for the elimination of many drugs, including theophylline.

Purpose of the Study:

• To investigate theophylline elimination in patients with chronic congestive heart failure.
• To determine the impact of liver congestion on theophylline pharmacokinetics.
• To identify the role of hepatic function in theophylline metabolism.

Main Methods:

• The study included 50 patients with chronic congestive heart failure (grade III/IV) and 20 controls.
• Theophylline clearance and half-life were measured.
• Cardiac diagnosis was based on clinical and hemodynamic parameters.
• Galactose elimination capacity was used to assess hepatic function.

Main Results:

• Theophylline body clearance was significantly reduced in heart failure patients with liver congestion (25.7 ml/kg/h) compared to controls (68.3 ml/kg/h).
• Theophylline half-life was prolonged in these patients (5.7 h) versus controls (3.1 h).
• A significant correlation was found between theophylline clearance and galactose elimination capacity (r=0.666, P<0.01).

Conclusions:

• Chronic congestive heart failure, particularly with liver congestion, significantly impairs theophylline elimination.
• Reduced hepatic tissue function is the primary factor responsible for altered theophylline pharmacokinetics.
• Monitoring theophylline levels may be crucial in heart failure patients to avoid toxicity.